These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28027731)

  • 1. Pathologic Findings and Long-Term Results After Surgical Treatment for Pulmonary Sarcomatoid Tumors: A Multicenter Analysis.
    Lococo F; Rapicetta C; Cardillo G; Stefani A; Margaritora S; Leuzzi G; Rossi G; Petracca Ciavarella L; Morandi U; Facciolo F; Ricchetti T; Cesario A; Paci M
    Ann Thorac Surg; 2017 Apr; 103(4):1142-1150. PubMed ID: 28027731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
    Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
    Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of vascular and lymphatic emboli in resected pulmonary adenocarcinoma.
    Strano S; Lupo A; Lococo F; Schussler O; Loi M; Younes M; Bobbio A; Damotte D; Regnard JF; Alifano M
    Ann Thorac Surg; 2013 Apr; 95(4):1204-10. PubMed ID: 23415237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor recurrence after complete resection for non-small cell lung cancer.
    Taylor MD; Nagji AS; Bhamidipati CM; Theodosakis N; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2012 Jun; 93(6):1813-20; discussion 1820-1. PubMed ID: 22542070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma.
    Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B;
    Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.
    Cox ML; Yang CJ; Speicher PJ; Anderson KL; Fitch ZW; Gu L; Davis RP; Wang X; D'Amico TA; Hartwig MG; Harpole DH; Berry MF
    J Thorac Oncol; 2017 Apr; 12(4):689-696. PubMed ID: 28082103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database.
    Rahouma M; Kamel M; Narula N; Nasar A; Harrison S; Lee B; Stiles B; Altorki NK; Port JL
    Eur J Cardiothorac Surg; 2018 Apr; 53(4):828-834. PubMed ID: 29240878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.
    Brunelli A; Pompili C; Berardi R; Mazzanti P; Onofri A; Salati M; Cascinu S; Sabbatini A
    Ann Thorac Surg; 2012 Jun; 93(6):1796-800. PubMed ID: 22551844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases.
    Sato T; Watanabe A; Kondo H; Kanzaki M; Okubo K; Yokoi K; Matsumoto K; Marutsuka T; Shinohara H; Teramukai S; Kishi K; Ebina M; Sugiyama Y; Meinoshin O; Date H;
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):64-9, 70.e1-2. PubMed ID: 25439777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
    Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
    Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
    Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
    Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung.
    Park JS; Lee Y; Han J; Kim HK; Choi YS; Kim J; Shim YM; Kim K
    Oncology; 2011; 81(3-4):206-13. PubMed ID: 22076573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.